Jazz Pharma Plc (JAZZ)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Results
download Want to compare other data? Select Fields| Symbol | JAZZ | BMRN | QGEN | ||
| Company | Jazz Pharma Plc | Biomarin Pharmaceuticals | Qiagen N.V. | ||
| Price Information | |||||
| Exchange | NASDAQ | NASDAQ | NYSE | ||
| Open | 170.62 | 55.00 | 48.20 | ||
| High | 172.59 | 55.23 | 48.40 | ||
| Low | 167.52 | 54.58 | 47.21 | ||
| Latest | 169.41 | 54.59 | 47.57 | ||
| Change | -1.75 | -0.48 | -0.81 | ||
| % Change | -1.02% | -0.87% | -1.67% | ||
| Volume | 1,110,300 | 2,076,400 | 1,957,900 | ||
| 20-Day Average Volume | 1,147,735 | 3,025,180 | 1,355,688 | ||
| Previous Close | 171.16 | 55.07 | 48.38 | ||
| Industry | Medical - Biomedical | Medical - Biomedical | Medical - Biomedical | ||
| Has Options | Yes | Yes | Yes | ||
| Technicals | |||||
| 20-Day Moving Average | 168.38 | 58.49 | 48.04 | ||
| 20-Day Raw Stochastic | 66.10% | 24.94% | 31.66% | ||
| 20-Day Relative Strength | 54.69 | 44.93 | 46.74 | ||
| Weighted Alpha | +43.15 | -12.16 | -3.16 | ||
| Today's Opinion | 88% Buy | 32% Sell | 64% Sell | ||
| Previous Opinion | 88% Buy | 32% Sell | 16% Sell | ||
| Last Month's Opinion | 88% Buy | 88% Sell | 48% Sell | ||
| Performance | |||||
| 5-Days | |||||
| %Chg | +5.14% since 01/09/26 | -7.40% since 01/09/26 | -1.49% since 01/09/26 | ||
| Low | 159.35 on 01/13/26 | 54.36 on 01/13/26 | 46.41 on 01/13/26 | ||
| High | 173.09 on 01/14/26 | 59.03 on 01/12/26 | 48.59 on 01/12/26 | ||
| 1-Month | |||||
| %Chg | -0.19% since 12/16/25 | +5.45% since 12/16/25 | +0.40% since 12/16/25 | ||
| Low | 156.95 on 01/08/26 | 51.50 on 12/18/25 | 46.41 on 01/13/26 | ||
| High | 175.80 on 01/05/26 | 63.89 on 12/19/25 | 50.07 on 01/07/26 | ||
| 3-Month | |||||
| %Chg | +26.19% since 10/16/25 | +3.10% since 10/16/25 | -6.11% since 10/16/25 | ||
| Low | 128.80 on 11/07/25 | 50.76 on 11/07/25 | 45.07 on 11/07/25 | ||
| High | 182.99 on 11/18/25 | 63.89 on 12/19/25 | 52.20 on 10/21/25 | ||
| 6-Month | |||||
| %Chg | +45.94% since 07/16/25 | -6.51% since 07/16/25 | -6.44% since 07/16/25 | ||
| Low | 105.00 on 08/06/25 | 50.76 on 11/07/25 | 45.07 on 11/07/25 | ||
| High | 182.99 on 11/18/25 | 63.97 on 08/05/25 | 54.61 on 07/25/25 | ||
| Key Statistics | |||||
| Market Capitalization, $K | 10,294,198 | 10,487,502 | 10,045,642 | ||
| Shares Outstanding, K | 60,765 | 192,114 | 211,176 | ||
| Annual Sales | 4,068,950,000 | 2,853,920,000 | 1,978,210,000 | ||
| Annual Net Income | 560,120,000 | 426,860,000 | 83,590,000 | ||
| Last Quarter Sales | 1,126,110,000 | 776,130,000 | 532,580,000 | ||
| Last Quarter Net Income | 251,410,000 | -30,740,000 | 130,040,000 | ||
| 60-Month Beta | 0.27 | 0.27 | 0.66 | ||
| Per-Share Information | |||||
| Most Recent Earnings | 8.13 on 11/05/25 | 0.12 on 10/27/25 | 0.61 on 11/04/25 | ||
| Latest Earnings Date | 02/24/26 | 02/18/26 | 02/04/26 | ||
| Most Recent Dividend | N/A | N/A | 0.250 on 07/02/25 | ||
| Next Ex-Dividends Date | N/A | N/A | 07/02/25 | ||
| Ratios | |||||
| Price/Earnings ttm | 40.56 | 19.19 | 19.39 | ||